Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 13 Prostatic Neoplasms 9 Carcinoma, Hepatocellular 8 Liver Neoplasms 6 Neoplasm Metastasis 3 Melanoma 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Unresectable Pancreatic Cancer 2 Stomach Neoplasms 2 Squamous Intraepithelial Lesions 2 Neoplasms 2 Lymphatic Metastasis 2 Locally Advanced Pancreatic Cancer 2 Kidney Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Adenocarcinoma Resectable 1 Pancreatic Adenocarcinoma Locally Advanced 1

Interventions

Gemcitabine 60 Cisplatin 38 Oxaliplatin 30 Capecitabine 28 Fluorouracil 21 Leucovorin 19 pembrolizumab 11 Irinotecan 11 durvalumab 9 130-nm albumin-bound paclitaxel 9 Erlotinib Hydrochloride 8 Trastuzumab 7 Bevacizumab 7 Platinum 6 Magnetic Resonance Spectroscopy 6 Albumin-Bound Paclitaxel 6 1,2-diaminocyclohexaneplatinum II citrate 6 Taxes 5 Specimen Handling 5 Sorafenib 5 Radiotherapy 5 Carboplatin 5 Docetaxel 4 Biopsy 4 trifluridine tipiracil drug combination 3 dehydroftorafur 3 atezolizumab 3 Paclitaxel 3 Lapatinib 3 Interleukin-12 Subunit p35 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Gallbladder Neoplasms × Electroporation × Clear all

NCT02430662 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡